カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の血液製剤市場2023-2030：製品別（全血、血液成分、血液派生物）、抗血栓剤・抗凝固剤種類別、用途別、地域別

【英語タイトル】Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And Anticoagulants Type, By Application, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV007）・商品コード：GRV23NOV007
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

血液製剤市場の成長と動向
Grand View Research社の最新レポートによると、世界の血液製剤市場規模は2030年までに735.9億米ドルに達する見込みです。同市場は2023年から2030年にかけてCAGR 6.4%で拡大する見込みです。市場を牽引する主な要因としては、血液関連疾患の有病率の増加、いくつかの外科手術における成分の広範な使用、輸血処置数の増加などが挙げられます。

怪我や事故の増加、献血の増加、献血に関する意識を高めるための政府のイニシアティブの高まりは、予測期間中に市場を推進すると予想されます。例えば、2022年11月に、世界保健機関/汎米保健機関（PAHO/WHO）は、米国からの資金援助を受けて、ベリーズで命を救うために自発的な寄付のためのプロモーションアイテムを寄贈することによって啓発プログラムを実施しました。さらに、血友病や遺伝性血管性浮腫のような多くの慢性および急性の生命を脅かす疾患に対する救命治療薬として、バイオ医薬品および製薬業界における血漿の使用量の増加は、血液製剤市場を後押しする可能性が高いです。

同市場の事業会社は、提携、M&A、製品上市など数多くの戦略に取り組んでいます。さらに、各社は需要に対応するため、製造施設の拡張に向けた投資の拡大にも注力しています。例えば、2023年5月、PlasmaGen Biosciences社は、インドにおける血漿製品の生産を強化するための新施設の開設を発表しました。この施設は、リーズナブルな価格の製品の需給シナリオを大幅に強化することを目的としています。

しかし、低血圧性輸血反応を含む輸血によるアレルギー反応の発生率の増加が、調査期間中の市場の妨げになると予想されています。さらに、B型肝炎、HIV、ウイルス性出血熱など、輸血中の疾病感染の変化が大きいことも、市場の妨げになる可能性があります。

一方、自動収集システムのような収集および処理技術の革新は、処理時間を短縮することにより、製品の品質を向上させることができます。例えば、2022年5月、Vitestro社は革新的な自律型採血装置を発表しました。この装置は、超音波ガイドによる3D再構築と人工知能（AI）を組み合わせたもので、安全で正確な採血のためにロボットによる針挿入を行います。このような取り組みは、予測期間中に有利な機会を生み出すと予測されています。

血液製剤市場レポートハイライト

- 製品別では、大手術や輸血の需要増加により、全血製剤セグメントが2022年に最大の市場シェアを獲得しました。

- タイプ別では、2022年に抗凝固剤がタイプ別セグメントを支配し、2023年から2030年にかけて有利なCAGRを記録する見込みです。この成長は、より高い有効性を持つ新製品の導入と、現在開発中の新製品の商業化の可能性に起因しています。

- 地域別では、北米はCVD、白血病、血液・神経疾患の発生率が高いため、2022年の売上高で市場全体をリードしました。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 市場変数・傾向・範囲
第4章 世界の血液製剤市場：製品別ビジネス分析
第5章 世界の血液製剤市場：抗血栓剤・抗凝固剤種類別ビジネス分析
第6章 世界の血液製剤市場：用途別ビジネス分析
第7章 世界の血液製剤市場：地域別ビジネス分析
第8章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Product & Application Snapshot
2.3. Anti-thrombotic & Anticoagulants Type Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Blood Preparation Market: Product Movement Analysis
4.2. Whole Blood
4.2.1. Whole Blood Market, 2018 – 2030 (USD Million)
4.2.2. Red Cells
4.2.2.1. Red Cells Market, 2018 – 2030 (USD Million)
4.2.3. Granulocytes
4.2.3.1. Granulocytes Market, 2018 – 2030 (USD Million)
4.2.4. Plasma
4.2.4.1. Plasma Market, 2018 – 2030 (USD Million)
4.2.5. Platelets
4.2.5.1. Platelets Market, 2018 – 2030 (USD Million)
4.3. Blood Components
4.3.1. Whole Blood Components
4.3.1.1. Whole Blood Components Market, 2018 – 2030 (USD Million)
4.3.2. Packed Red Cells
4.3.2.1. Packed Red Cells Market, 2018 – 2030 (USD Million)
4.3.3. Leukocyte Reduced Red Blood Cells
4.3.3.1. Leukocyte Reduced Red Blood Cells Market, 2018 – 2030 (USD Million)
4.3.4. Frozen Plasma
4.3.4.1. Frozen Plasma Market, 2018 – 2030 (USD Million)
4.3.5. Platelet Concentrate
4.3.5.1. Whole Blood Components Market, 2018 – 2030 (USD Million)
4.3.6. Cryoprecipitate
4.3.6.1. Cryoprecipitate Market, 2018 – 2030 (USD Million)
4.4. Blood Derivatives
4.4.1. Blood Derivatives Market, 2018 – 2030 (USD Million)
Chapter 5. Anti-Thrombotic and Anticoagulants Type Business Analysis
5.1. Blood Preparation Market: Anti-Thrombotic and Anticoagulants Type Movement Analysis
5.2. Platelet Aggregation Inhibitors
5.2.1. Platelets Aggregation Inhibitors Market, 2018 – 2030 (USD Million)
5.2.2. Glycoprotein Inhibitors
5.2.2.1. Glycoprotein Inhibitors Market, 2018 – 2030 (USD Million)
5.2.3. COX Inhibitors
5.2.3.1. COX Inhibitors Market, 2018 – 2030 (USD Million)
5.2.4. ADP Antagonist
5.2.4.1. ADP Antagonist Market, 2018 – 2030 (USD Million)
5.2.5. Others
5.2.5.1. Others Market, 2018 – 2030 (USD Million)
5.3. Fibrinolytics
5.3.1. Fibrinolytics Market, 2018 – 2030 (USD Million)
5.3.2. Tissue Plasminogen Activator
5.3.2.1. Others Market, 2018 – 2030 (USD Million)
5.3.3. Streptokinase
5.3.3.1. Streptokinase Market, 2018 – 2030 (USD Million)
5.3.4. Urokinase
5.3.4.1. Urokinase Market, 2018 – 2030 (USD Million)
5.4. Anticoagulants
5.4.1. Anticoagulants Market, 2018 – 2030 (USD Million)
5.4.2. Heparins
5.4.2.1. Heparins Market, 2018 – 2030 (USD Million)
5.4.2.2. Unfractionated heparin
5.4.2.2.1. Unfractionated heparin Market, 2018 – 2030 (USD Million)
5.4.2.3. Low Molecular Weight heparin
5.4.2.3.1. Low Molecular Weight Heparin Market, 2018 – 2030 (USD Million)
5.4.2.4. Ultra-Low Molecular Weight Heparin
5.4.2.4.1. Ultra-Low Molecular Weight Heparin Market, 2018 – 2030 (USD Million)
5.4.3. Vitamin K Antagonist
5.4.3.1. Vitamin K Antagonist Market, 2018 – 2030 (USD Million)
5.4.4. Direct Thrombin Inhibitors
5.4.4.1. Direct Thrombin Inhibitors Market, 2018 – 2030 (USD Million)
5.4.5. Direct factor Xa inhibitors
5.4.5.1. Direct factor Xa Inhibitors Market, 2018 – 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Thrombocytosis
6.1.1. Thrombocytosis Market, 2018 – 2030 (USD Million)
6.2. Pulmonary Embolism
6.2.1. Pulmonary Embolism Market, 2018 – 2030 (USD Million)
6.3. Renal Impairment
6.3.1. Renal Impairment Market, 2018 – 2030 (USD Million)
6.4. Angina Blood Vessel Complication
6.4.1. Angina Blood Vessel Complication Market, 2018 – 2030 (USD Million)
6.5. Others
6.5.1. Other Application Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Blood Preparation Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Blood Preparation Market, 2018 – 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Blood Preparation Market, 2018 – 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Blood Preparation Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Blood Preparation Market, 2018 – 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. UK Blood Preparation Market, 2018 – 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Germany Blood Preparation Market, 2018 – 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. France Blood Preparation Market, 2018 – 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Italy Blood Preparation Market, 2018 – 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Spain Blood Preparation Market, 2018 – 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Denmark Blood Preparation Market, 2018 – 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Sweden Blood Preparation Market, 2018 – 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Norway Blood Preparation Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Blood Preparation Market, 2018 – 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Japan Blood Preparation Market, 2018 – 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. China Blood Preparation Market, 2018 – 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. India Blood Preparation Market, 2018 – 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Australia Blood Preparation Market, 2018 – 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Thailand Blood Preparation Market, 2018 – 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. South Korea Blood Preparation Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Blood Preparation Market, 2018 – 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Brazil Blood Preparation Market, 2018 – 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Mexico Blood Preparation Market, 2018 – 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Argentina Blood Preparation Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Blood Preparation Market, 2018 – 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. South Africa Blood Preparation Market, 2018 – 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Saudi Arabia Blood Preparation Market, 2018 – 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. UAE Blood Preparation Market, 2018 – 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Kuwait Blood Preparation Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Strategic Framework
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Pfizer, Inc
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Bristol-Myers Squibb Company
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Leo Pharma A/S
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Sanofi
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Xiamen Hisunny Chemical Co., LTD
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. AstraZeneca plc
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Baxter International Inc
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Blood Preparation Market, by Product, 2018 - 2030 (USD Million)
Table 4. Global Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 5. Global Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 6. Global Blood Preparation Market, by Region, 2018 - 2030 (USD Million)
Table 7. North America Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 8. North America Blood Preparation Market, by Technology, 2018 - 2030 (USD Million)
Table 9. North America Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 10. North America Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 11. U.S. Blood Preparation Market, by Technology, 2018 - 2030 (USD Million)
Table 12. U.S. Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 13. U.S. Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 14. Canada Blood Preparation Market, by Technology, 2018 - 2030 (USD Million)
Table 15. Canada Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 16. Canada Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 17. Europe Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 18. Europe Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 19. Europe Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 20. Europe Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 21. Germany Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 22. Germany Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 23. Germany Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 24. UK Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 25. UK Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 26. UK Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 27. France Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 28. France Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 29. France Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 30. Italy Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 31. Italy Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 32. Italy Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 33. Spain Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 34. Spain Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 35. Spain Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 36. Sweden Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 37. Sweden Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 38. Sweden Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 39. Denmark Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 40. Denmark Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 41. Denmark Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 42. Norway Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 43. Norway Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 44. Norway Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 45. Asia Pacific Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 46. Asia Pacific Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 47. Asia Pacific Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 48. Asia Pacific Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 49. China Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 50. China Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 51. China Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 52. Japan Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 53. Japan Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 54. Japan Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 55. India Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 56. India Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 57. India Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 58. South Korea Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 59. South Korea Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 60. South Korea Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 61. Australia Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 62. Australia Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 63. Australia Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 64. Thailand Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 65. Thailand Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 66. Thailand Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 67. Latin America Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 68. Latin America Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 69. Latin America Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 70. Latin America Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 71. Brazil Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 72. Brazil Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 73. Brazil Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 74. Mexico Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 75. Mexico Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 76. Mexico Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 77. Argentina Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 78. Argentina Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 79. Argentina Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa Blood Preparation Market, by Country, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 83. Middle East & Africa Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 84. South Africa Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 85. South Africa Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 86. South Africa Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 90. UAE Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 91. UAE Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 92. UAE Blood Preparation Market, by Application, 2018 - 2030 (USD Million)
Table 93. Kuwait Blood Preparation Market, by Type, 2018 - 2030 (USD Million)
Table 94. Kuwait Blood Preparation Market, by Antithrombotic & Anticoagulants Type, 2018 - 2030 (USD Million)
Table 95. Kuwait Blood Preparation Market, by Application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Blood Preparation, Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Blood Preparation Market: Product Movement Analysis
Fig. 17 Global Blood Preparation Market, for Whole Blood,2018 - 2030 (USD Million)
Fig. 18 Global Blood Preparation Market, for Red Cells,2018 - 2030 (USD Million)
Fig. 19 Global Blood Preparation Market, for Granulocytes,2018 - 2030 (USD Million)
Fig. 20 Global Blood Preparation Market, for Plasma ,2018 - 2030 (USD Million)
Fig. 21 Global Blood Preparation Market, for Platelets,2018 - 2030 (USD Million)
Fig. 22 Global Blood Preparation Market, for Blood Components,2018 - 2030 (USD Million)
Fig. 23 Global Blood Preparation Market, for Whole Blood Components,2018 - 2030 (USD Million)
Fig. 24 Global Blood Preparation Market, for Packed Red Cells,2018 - 2030 (USD Million)
Fig. 25 Global Blood Preparation Market, for Leukocyte Reduced Red Blood Cells,2018 - 2030 (USD Million)
Fig. 26 Global Blood Preparation Market, for Frozen Plasma,2018 - 2030 (USD Million)
Fig. 27 Global Blood Preparation Market, for Platelet Concentrate,2018 - 2030 (USD Million)
Fig. 28 Global Blood Preparation Market, for Cryoprecipitate,2018 - 2030 (USD Million)
Fig. 29 Global Blood Preparation Market, for Blood Derivatives,2018 - 2030 (USD Million)
Fig. 30 Global Blood Preparation Market: Antithrombotic & Anticoagulants Type Movement Analysis
Fig. 31 Global Blood Preparation Market, for Platelet Aggregation Inhibitors,2018 - 2030 (USD Million)
Fig. 32 Global Blood Preparation Market, for Glycoprotein Inhibitors,2018 - 2030 (USD Million)
Fig. 33 Global Blood Preparation Market, for COX Inhibitors,2018 - 2030 (USD Million)
Fig. 34 Global Blood Preparation Market, for ADP Antagonists,2018 - 2030 (USD Million)
Fig. 35 Global Blood Preparation Market, for Others,2018 - 2030 (USD Million)
Fig. 36 Global Blood Preparation Market, for Fibrinolytics,2018 - 2030 (USD Million)
Fig. 37 Global Blood Preparation Market, for Tissue Plasminogen Activator (tPA),2018 - 2030 (USD Million)
Fig. 38 Global Blood Preparation Market, for Streptokinase,2018 - 2030 (USD Million)
Fig. 39 Global Blood Preparation Market, for Urokinase,2018 - 2030 (USD Million)
Fig. 40 Global Blood Preparation Market, for Anticoagulants,2018 - 2030 (USD Million)
Fig. 41 Global Blood Preparation Market, for Heparins,2018 - 2030 (USD Million)
Fig. 42 Global Blood Preparation Market, for Unfractionated Heparin,2018 - 2030 (USD Million)
Fig. 43 Global Blood Preparation Market, for Low Molecular Weight Heparin (LMWH),2018 - 2030 (USD Million)
Fig. 44 Global Blood Preparation Market, for Ultra-low Molecular Weight Heparin,2018 - 2030 (USD Million)
Fig. 45 Global Blood Preparation Market, for Vitamin K Antagonists,2018 - 2030 (USD Million)
Fig. 46 Global Blood Preparation Market, for Direct Thrombin Inhibitors,2018 - 2030 (USD Million)
Fig. 47 Global Blood Preparation Market, for Direct Factor Xa Inhibitors,2018 - 2030 (USD Million)
Fig. 48 Global Blood Preparation Market, : Application Movement Analysis
Fig. 49 Global Blood Preparation Market, for Thrombocytosis,2018 - 2030 (USD Million)
Fig. 50 Global Blood Preparation Market, for Pulmonary Embolism,2018 - 2030 (USD Million)
Fig. 51 Global Blood Preparation Market, for Renal Impairment,2018 - 2030 (USD Million)
Fig. 52 Global Blood Preparation Market, for Angina Blood Vessel Complications,2018 - 2030 (USD Million)
Fig. 53 Global Blood Preparation Market, for Others,2018 - 2030 (USD Million)
Fig. 54 Regional Marketplace: Key Takeaways
Fig. 55 Regional Outlook, 2022 & 2030
Fig. 56 Global Blood Preparation Market, : Region Movement Analysis
Fig. 57 North America Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 58 U.S. Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 59 Canada Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 60 Europe Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 61 Germany Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 62 UK Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 63 France Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 64 Italy Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 65 Spain Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 66 Sweden Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 67 Denmark Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 68 Norway Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 69 Asia Pacific Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 70 Japan Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 71 China Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 72 India Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 73 Australia Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 74 South Korea Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 75 Thailand Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 76 Latin America Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 77 Brazil Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 78 Mexico Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 79 Argentina Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 80 Middle East and Africa Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 81 South Africa Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 82 Saudi Arabia Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 83 UAE Blood Preparation Market, 2018 - 2030 (USD Million)
Fig. 84 Kuwait Blood Preparation Market, 2018 - 2030 (USD Million)

★調査レポート[世界の血液製剤市場2023-2030：製品別（全血、血液成分、血液派生物）、抗血栓剤・抗凝固剤種類別、用途別、地域別] (コード：GRV23NOV007)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血液製剤市場2023-2030：製品別（全血、血液成分、血液派生物）、抗血栓剤・抗凝固剤種類別、用途別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の血液製剤市場予測2023年-2028年：製品別（全血、血液成分、血液誘導体）、抗血栓薬・抗凝固薬種類別（血小板凝集抑制薬、線溶薬、抗凝固薬）、抗血栓薬・抗凝固薬用途別（血小板減少症、肺塞栓症、腎障害、狭心症血管合併症、その他）、地域別
  • 血液検査の世界市場2023-2030：市場規模、シェア、動向分析
  • 血液検査の世界市場2023-2030：市場規模、シェア、動向分析
  • 世界の抗ウイルス薬市場2023-2030：タイプ別（ブランド、ジェネリック）、薬剤クラス別、流通チャネル別（病院薬局、小売薬局）、用途別、地域別
  • 鎌状赤血球症治療の世界市場2023-2030：市場規模、シェア、動向分析
  • 鎌状赤血球症治療の世界市場2023-2030：市場規模、シェア、動向分析
  • 世界の鎌状赤血球症治療市場2024-2030：治療別（輸血、骨髄移植）、エンドユーザー別（病院、専門クリニック）、地域別
  • 世界のシーケンス消耗品市場2024-2030：製品別（キット、試薬、付属品）、プラットフォーム別（第1世代、第2世代、第3世代）、用途別、エンドユーザー別、地域別
  • 世界のロボット支援内視鏡市場（2023-2030）：用途別（病院、外来施設）、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）
  • 世界の緑内障市場2023-2030：疾患種類別（開放隅角緑内障、閉塞隅角緑内障）、薬剤クラス別（プロスタグランジン類縁体、ベータ遮断薬）、流通チャネル別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆